Liquent and Take Solutions team on regulatory submissions

By Gareth Macdonald

- Last updated on GMT

Related tags: Pharmacology

Liquent and Take Solutions team on regulatory submissions
Liquent and Take Solutions say their new partnership provides pharmaceutical firms with an efficient, cost effective outsourced solution for regulatory publication and submissions.

Liquent VP of sales and marketing Jeff Huntsman told Outsourcing-pharma that drug firms often lack in-house capacity to effectively manage the production of regulatory documents and that was a key driver for the deal with electronic submissions specialist Take Solutions.

He explained the alliance combines Liquent's regulatory expertise with Take's existing infrastructure to provide efficiencies adding that "Take is a very strong partner from a standpoint of having offshore resources and [of working within] compliance and efficiency guidelines.​"

Huntsman went on to say that Liquent is seeing considerable demand from regulatory services from large pharma firms, particularly for “non-strategic” products where the challenge is to produce the required regulatory documents in as efficient a way as possible.

He also said that, while this market is strong in Europe and the US, Asia has been slower to adapt to the eCTD model and as a result there has been less demand for outsourced submissions solutions.

Related news

Show more

Related products

show more

GLP Tissue Cross Reactivity Testing

GLP Tissue Cross Reactivity Testing

Precision for Medicine | 11-Oct-2021 | Product Brochure

Precision for Medicine's unique combination of research services and tissue procurement capabilities form the pillars of our GLP Tissue Cross Reactivity...

Automating clinical trials for success

Automating clinical trials for success

Formedix | 06-Oct-2021 | Technical / White Paper

This article gives gives a brief overview of why automation is absolutely essential for clinical trial success.

Related suppliers

Follow us

Products

View more

Webinars